Fintel reports that on February 4, 2025, Wolfe Research initiated coverage of Vera Therapeutics (NasdaqGM:VERA) with a ...
Wolfe Research reiterated its optimistic stance on Match Group (NASDAQ:MTCH) shares, maintaining an Outperform rating and a $40.00 price target. According to InvestingPro analysis, Match Group appears ...
Wolfe Research has recently raised FTAI Aviation Ltd (FTAI) stock to Outperform rating, as announced on January 10, 2025, according to Finviz. Earlier, on December 31, 2024, BTIG Research had ...
Wolfe Research initiated coverage of Vera Therapeutics (VERA) with an Outperform rating and $49 price target The firm is bullish on the stock ...
Wolfe Research analyst Andy Chen initiated coverage of AnaptysBio (ANAB) with an Outperform rating and $25 price target The stock’s current ...
Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 1.12% of ...
Investing.com - U.S. President Donald Trump's decision to impose tariffs on America's closest trading partners means that ...
Netflix's stock rating was upgraded to "outperform" by Wolfe Research after surpassing 300 million paid memberships and ...
Investing.com -- Wolfe Research downgraded Lam Research Corp (NASDAQ:LRCX) to "Peer Perform" on bearish views on NAND and the stock’s valuation premium over Applied Materials (NASDAQ:AMAT).
Wolfe Research has announced its top financial sector stock recommendations for 2025, stressing a selective approach to retail brokers, wealth managers, and alternative investing organizations.
Wolfe Research analysts said software (NYSEARCA:XSW), (IGPT) is a key area of M&A opportunities in 2025. Chris Senyek, chief investment strategist at Wolfe Research, said in a note that this is ...
FirstEnergy (NYSE:FE) -1.3% in Thursday's trading as Wolfe Research downgrades shares to Peer Perform from Outperform with fair value at $38-$43, seeing concerns on low-quality pension and coal ...